Corebridge Financial’s Insmed INSM Stock Holding History

Corebridge Financial’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-84,466	Closed	-$6.44M	–	1339
2025 Q1	$6.44M	Sell	84,466 -1,253	-1%	-$95.8K	0.04%	570
2024 Q4	$5.92M	Buy	85,719 +1,685	+2%	+$121K	0.03%	648
2024 Q3	$6.13M	Buy	84,034 +467	+0.6%	+$34.5K	0.03%	648
2024 Q2	$5.6M	Buy	+83,567	New	+$3.24M	0.03%	665

Other funds holding INSM

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Corebridge Financial's INSM Position: Q2 2025 in Review

Corebridge Financial sold out of Insmed (INSM) in Q2 2025, closing a stake of 84,466 shares — an estimated $6.44M sold.

Corebridge Financial first reported a position in INSM in Q2 2024 and held it in 4 quarters. The position peaked at $6.44M in Q1 2025. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

Corebridge Financial reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
Corebridge Financial sold 84,466 Insmed shares in Q2 2025, an estimated $6.44M.
Corebridge Financial first reported a position in Insmed in Q2 2024 and held it in 4 quarters.
Corebridge Financial's Insmed position peaked at $6.44M in Q1 2025.
516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.